When was Emalex Biosciences founded?

Emalex Biosciences was founded in 2018.

Where is Emalex Biosciences headquartered?

Emalex Biosciences is headquartered in Northbrook, Illinois, United States.

What industry is Emalex Biosciences in?

Emalex Biosciences operates in Biotech, Healthcare.

How many employees does Emalex Biosciences have?

Emalex Biosciences has 51-200 employees.

Emalex Biosciences

Closed

Northbrook, United States · Founded 2018

Biotech

Healthcare

Headquarters: Northbrook, Illinois
Employees: 51–200

Founded: 2018
Business Model: B2B

About

Emalex Biosciences was a CNS-focused biopharmaceutical company founded in 2018 by Jeffrey Aronin under parent company Paragon Biosciences, dedicated to developing novel therapies for Tourette syndrome and other neurological disorders. The company advanced a first-in-class investigational compound (ecopipam) through late-stage clinical development, earning recognition as Neuroscience Therapeutics Company of the Year. In June 2026, Teva Pharmaceuticals completed its acquisition of Emalex, adding the NDA-ready asset to Teva's neuroscience pipeline as part of its Pivot to Growth strategy.

Summary

Emalex Biosciences is a Biotech company based in Northbrook, United States, founded in 2018.